4

OWNERSHIP DOCUMENT

Company: Actinium Pharmaceuticals, Inc.
Filed: May 26, 2016
Period of Report: May 25, 2016
Accession Number: 0000921895-16-004701

View Document ↗ View on SEC.gov ↗